COVID-19

Danaher Reports Fourth Quarter and Full Year 2024 Results

WASHINGTON, Jan. 29, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and…

11 months ago

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan…

11 months ago

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)…

11 months ago

XORTX to Present at Microcap Conference

CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…

11 months ago

Transmission Electron Microscope Market to grow by USD 528.8 Million (2024-2028), driven by nanotechnology focus, AI-driven market transformation – Technavio

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global transmission electron microscope…

11 months ago

Cooper University Health Care Breaks Ground on First Phase of $3 Billion “Project Imagine” Expansion in Camden

Camden, New Jersey--(Newsfile Corp. - January 28, 2025) - Today, Cooper University Health Care held a groundbreaking ceremony on the…

11 months ago

Jiva Technologies Announces the Launch of www.LIV3Health.com, Kicking Off Presale Orders for Revolutionary SugarShield Supplement

VANCOUVER, BC, Jan. 28, 2025 /PRNewswire/ -- Jiva Technologies (CSE: JIVA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("JIVA" or the "Company"), a…

11 months ago

Sera Prognostics to Host Virtual R&D Day on January 31

Event will showcase results of Company's pivotal PRIME study and include the principal investigator SALT LAKE CITY, Jan. 27, 2025…

11 months ago

Hemostemix Up-lists to TradeGateExchange in Germany

Calgary, Alberta--(Newsfile Corp. - January 27, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

11 months ago

Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is designed for…

11 months ago